KR-102963443-B1 - A functional composition that improves sex hormone imbalance by suppressing excessive secretion of growth hormone caused by childhood obesity and helps reduce body fat by regulating adipokines

Abstract

The present invention provides a functional composition that helps reduce body fat, comprising Astragalus extract powder, resveratrol, Polygonum multiflorum extract powder, Ulmus davidiana bark extract powder, ginseng extract powder, Paeonia lactiflora extract powder, Cnidium officinale extract powder, Acanthopanax senticosus extract powder, chicory extract powder, Polygonum multiflorum extract powder, broccoli concentrate powder, fructooligosaccharide, fermented gold kiwi powder, and kiwi concentrate powder. The functional composition according to the present invention improves sex hormone imbalance by suppressing the oversecretion of growth hormone caused by childhood obesity and helps reduce body fat through adipokine regulation.

Inventors

• 이성탄

Dates

Publication Date

20260511

Application Date

20251104

Claims (6)

1. 0.8-1.2 parts by weight of Astragalus extract powder, 0.8-1.2 parts by weight of resveratrol, 0.8-1.2 parts by weight of Polygonum multiflorum extract powder, 0.8-1.2 parts by weight of Ulmus davidiana bark extract powder, 0.8-1.2 parts by weight of Ginseng extract powder, 0.8-1.2 parts by weight of Paeonia lactiflora extract powder, 0.8-1.2 parts by weight of Cnidium officinale extract powder, 0.8-1.2 parts by weight of Acanthopanax senticosus extract powder, 8-12 parts by weight of chicory extract powder, 0.8-1.2 parts by weight of Polygonum multiflorum extract powder, 20-22 parts by weight of broccoli concentrate powder, 18-22 parts by weight of fructooligosaccharide, 0.08-0.12 parts by weight of fermented gold kiwi powder, 8-12 parts by weight of complex extract powder and kiwi concentrate powder Contains 38-42 parts by weight, A functional composition that helps reduce body fat, characterized in that the above-mentioned complex extract powder is an extract powder obtained from a complex mixture of Mongolian oak leaves, Phellodendron amurense stems, and Malus kousa in a weight ratio of 1:1:1.
2. delete
3. delete
4. delete
5. delete
6. delete

Description

A functional composition that improves sex hormone imbalance by suppressing excessive secretion of growth hormone caused by childhood obesity and helps reduce body fat by regulating adipokines The present invention relates to a functional composition that helps reduce body fat, and more specifically, to a functional composition that helps reduce body fat by suppressing the oversecretion of growth hormone caused by childhood obesity to improve sex hormone imbalance and by regulating adipokines. Recently, the obese population has been increasing due to changes in dietary patterns resulting from the development of industrial society and improvements in living standards. Obesity refers to a condition in which body fat is excessively accumulated; it does not simply mean being overweight, but rather signifies an excessive accumulation of fat within the body due to metabolic disorders. In other words, calorie intake exceeds the energy required for physical activity and growth, leading to the excessive accumulation of triglycerides in adipose tissue and causing obesity. Obesity, in itself, not only causes damage to appearance, discomfort, and inefficiency but also induces diseases such as hyperlipidemia, hypertension, arteriosclerosis, cardiovascular diseases like myocardial infarction, kidney failure, type 2 insulin-independent diabetes, and lung disease, leading to the so-called "5D phenomenon" where these diseases can ultimately result in death. Beyond being an external issue, obesity is well known as a risk factor for cardiovascular diseases like heart disease and stroke, as well as liver disease, diabetes, cancer, and hypertension, due to the overweight condition. Currently, obesity affects all age groups, with a particularly high incidence among middle-aged adults. The mechanism leading to obesity involves the excessive intake of carbohydrates, which are digested into monosaccharides and absorbed into the body through the small intestine. As blood sugar levels rise, insulin is secreted in response to this stimulation, acting on fat cells to absorb monosaccharides from the blood and convert them into fat. It is also triggered by complex causes, including genetic factors. Meanwhile, childhood obesity is a serious medical disorder characterized by hyperplasia (increase in cell number) and hypertrophy (increase in cell size). The global prevalence of obese and overweight children is increasing in Westernized and industrialized countries, and a high body mass index (BMI) during childhood further leads to adult obesity with serious health consequences such as hypertension, type 2 diabetes (T2D), hyperlipidemia, and related metabolic disorders (D.M. Allcock, et al., Int J Pediatr Endocrinol (2009) 108187; L.J. Lloyd, et al., Int J Obes(Lond) 36(2012) 1-11; M. Juonala et al., N Engl J Med 365(2011) 1876-1885). Given that childhood adiposity is heritable, genetic variations may play an important role in early-onset obesity and childhood obesity (C. Bouchard, et al., Am J Clin Nutr 89 (2009) 1494S-1501S; J. Zhao, et al., J Obes (2011) 845148). Currently, various methods are being attempted to treat obesity. Generally, treatments for obesity include dietary therapy, exercise therapy, drug therapy using appetite suppressants, diuretics, laxatives, or fiber to provide a feeling of fullness, behavioral modification therapy to correct poor eating habits and lifestyle habits, surgical therapy to reduce the volume of the intestines or stomach in surgery, and liposuction, such as methods to break down and remove fat cells using ultrasound in plastic surgery. In addition, various side effects have been observed with amphetamines, Reductil, thiazolidineon, metformin, and other drugs associated with obesity treatment. For this reason, interest in alternative approaches, including the use of medicinal plants, has recently increased in relation to obesity improvement, and there is a need to develop new compositions for the prevention and improvement of obesity from natural products that have been recognized for their safety in the body. Various embodiments are described in more detail below. The embodiments described herein may be modified in various ways. Specific embodiments may be described in detail in the detailed description. However, the specific embodiments disclosed are intended only to facilitate understanding of various embodiments. Accordingly, the technical concept is not limited by the specific embodiments disclosed, and it should be understood that it includes all equivalents or substitutions that fall within the spirit and scope of the invention. Terms including ordinal numbers, such as first, second, first, second, etc., may be used to describe various components, but these components are not limited by the aforementioned terms. The aforementioned terms are used solely for the purpose of distinguishing one component from another. In this specification, terms such as "comprising" or "having" are intended to indicate